Menu
Search
|

Menu

Close
X

Nuvectra Corp NVTR.OQ (NASDAQ Stock Exchange Global Market)

18.44 USD
+0.27 (+1.49%)
As of Nov 17
chart
Previous Close 18.17
Open 18.01
Volume 33,211
3m Avg Volume 68,493
Today’s High 18.92
Today’s Low 18.01
52 Week High 25.17
52 Week Low 7.65
Shares Outstanding (mil) 10.70
Market Capitalization (mil) 143.81
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY18
38
FY17
32
FY16
13
FY15
5
EPS (USD)
FY18
-2.545
FY17
-3.974
FY16
-3.738
FY15
-2.380
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.59
Price to Sales (TTM)
vs sector
7.13
5.69
Price to Book (MRQ)
vs sector
2.16
5.11
Price to Cash Flow (TTM)
vs sector
--
23.52
Total Debt to Equity (MRQ)
vs sector
21.45
15.71
LT Debt to Equity (MRQ)
vs sector
19.16
11.53
Return on Investment (TTM)
vs sector
-46.19
15.05
Return on Equity (TTM)
vs sector
-53.53
16.62

EXECUTIVE LEADERSHIP

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

5830 Granite Pkwy Ste 1100
PLANO   TX   75024

Phone: +1972.6684107

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).

SPONSORED STORIES